The European Union’s drug regulator said it would review two studies that linked Novo Nordisk’s blockbuster diabetes drug ...

Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains ...

As Cytokinetics’ aficamten awaits approval decisions from regulators in the U.S. and China, Sanofi has picked up China rights ...

Following an appeal by the Danish Medicines Agency, the European Union’s drug regulator will review two new studies that have ...

Applied Therapeutics, Inc. (APLT), a biopharmaceutical company, Friday announced that Shoshana Shendelman has stepped down as Chair ...

The Polish initiative establishes a proactive strategy for securing access to essential medicines and maintaining ...

European Medicines Agency grants orphan drug designation for Neurizon’s lead drug candidate NUZ-001 to treat Amyotrophic ...

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

The European MCL Network Phase 3 TRIANGLE study, evaluated ibrutinib in combination with induction immunochemotherapy, both with and without an autologous stem cell transplant, followed by 24 months f ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...